HIV Type 1 Viral Infectivity Factor and the RUNX Transcription Factors Interact with Core Binding Factor β on Genetically Distinct Surfaces

被引:0
|
作者
Hultquist, Judd F. [1 ,2 ]
McDougle, Rebecca M. [1 ]
Anderson, Brett D. [1 ]
Harris, Reuben S. [1 ,2 ]
机构
[1] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Ctr Genome Engn,Masonic Canc Ctr, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Mol Cellular Dev Biol & Genet, Minneapolis, MN 55455 USA
关键词
APOBEC3 RESTRICTION FACTORS; E3 UBIQUITIN LIGASE; CBF-BETA; DNA-BINDING; FACTOR ALPHA; SOCS-BOX; VIF; COMPLEX; DOMAIN; DEGRADATION;
D O I
10.1089/aid.2012.0142
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) requires the cellular transcription factor core binding factor subunit beta (CBF beta) to stabilize its viral infectivity factor (Vif) protein and neutralize the APOBEC3 restriction factors. CBF beta normally heterodimerizes with the RUNX family of transcription factors, enhancing their stability and DNA-binding affinity. To test the hypothesis that Vif may act as a RUNX mimic to bind CBF beta, we generated a series of CBF beta mutants at the RUNX/CBF beta interface and tested their ability to stabilize Vif and impact transcription at a RUNX-dependent promoter. While several CBF beta amino acid substitutions disrupted promoter activity, none of these impacted the ability of CBF beta to stabilize Vif or enhance degradation of APOBEC3G. A mutagenesis screen of CBF beta surface residues identified a single amino acid change, F68D, that disrupted Vif binding and its ability to degrade APOBEC3G. This mutant still bound RUNX and stimulated RUNX-dependent transcription. These separation-of-function mutants demonstrate that HIV-1 Vif and the RUNX transcription factors interact with cellular CBF beta on genetically distinct surfaces.
引用
收藏
页码:1543 / 1551
页数:9
相关论文
共 50 条
  • [21] Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription
    Carr, Jillian M.
    Coolen, Carl
    Davis, Adam J.
    Burrell, Christopher J.
    Li, Peng
    VIROLOGY, 2008, 372 (01) : 147 - 156
  • [22] The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein
    Loregian, A
    Bortolozzo, K
    Boso, S
    Sapino, B
    Betti, M
    Biasolo, MA
    Caputo, A
    Palú, G
    JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 196 (02) : 251 - 257
  • [23] Core binding factor β protects osteoarthritis progression by inhibiting proteosomal degradation of Runx1
    Che, Xiangguo
    Jin, Xian
    Hong, Yu-Min
    Lee, Dong-Kyo
    Kim, Byung-Deu
    Park, Na-Rae
    Kim, Hyun-Ju
    Choi, Je-Yong
    Park, Eui-Kyun
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 225 - 225
  • [24] Editor's Note 'Transcription factor binding sites in the pol geneintragenic regulatory region of HIV-1 are important for virus infectivity'
    Sale, Julian E.
    Stoddard, Barry L.
    NUCLEIC ACIDS RESEARCH, 2024, 53 (01)
  • [25] Dissecting the role of Sp transcription factor binding sites on viral transcription in HIV-1 long terminal repeats derived from HIV-1 dementia patients
    Gray, Lachlan R.
    Cowley, Daniel J.
    Gorry, Paul R.
    Wesselingh, Steve L.
    Churchill, Melissa J.
    JOURNAL OF NEUROVIROLOGY, 2010, 16 : 35 - 36
  • [26] Developmental utilization of distinct promoters regulating the type I and type II isoforms of the bone Runx2/Cbfa1 transcription factor.
    Drissi, H
    Javed, A
    Balint, E
    Banerjee, C
    Adamidou, F
    Van Wijnen, AJ
    Stein, JL
    Stein, GS
    Lian, JB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S205 - S205
  • [27] Distinct RE-1 silencing transcription factor-containing complexes interact with different target genes
    Belyaev, ND
    Wood, IC
    Bruce, AW
    Street, M
    Trinh, JB
    Buckley, NJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 556 - 561
  • [28] Isolation and expression analysis of the factors that interact to the embryo specific transcription factor C-LEC1.
    Yazawa, K
    Kamada, H
    PLANT AND CELL PHYSIOLOGY, 2004, 45 : S106 - S106
  • [29] An In silico Approach for Identification of Novel Inhibitors as a Potential Therapeutics Targeting HIV-1 Viral Infectivity Factor
    Sinha, Chanda
    Nischal, Anuradha
    Bandaru, Srinivas
    Kasera, Priyadarshani
    Rajput, Ashish
    Nayarisseri, Anuraj
    Khattri, Sanjay
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (01) : 65 - 72
  • [30] RUNX1 ORCHESTRATES THE ESTABLISHMENT OF ALTERNATE TRANSCRIPTION FACTOR BINDING PATTERNS DURING THE ENDOTHELIAL - HEMATOPOIETIC TRANSITION
    Bonifer, Constanze
    Lichtinger, Monika
    Ingram, Richard
    Hannah, Rebecca
    Clarke, Deborah
    Mueller, Dorothee
    Lie-A-Ling, Michael
    Noailles, Laura
    Wu, Mengchu
    Assi, Salam
    Tenen, Daniel
    Westhead, David
    Kouskoff, Valerie
    Lacaud, George
    Goettgens, Berthold
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S39 - S39